Alphafold Protein Ligand Docking: Structural Analysis and Computational Methodologies in Bioinformatics

Introduction

The accurate prediction of protein-ligand interactions remains a cornerstone of structure-based drug design and mechanistic biochemistry. Traditional molecular docking depends on experimentally determined high-resolution protein structures, which are costly and time-consuming to obtain [1, 2]. AlphaFold, a deep learning-based method developed for protein structure prediction, has transformed the field by generating highly accurate three-dimensional protein models directly from amino acid sequences [3]. The subsequent release of AlphaFold 3 extended this capability to the joint prediction of complexes containing proteins, nucleic acids, small molecules, ions, and modified residues, enabling direct modeling of protein-ligand interactions within a unified deep learning framework [3]. This article reviews the computational methodologies for using AlphaFold-predicted structures in protein-ligand docking, with emphasis on structural analysis, benchmarking, and applications in veterinary medicine and virology.

AlphaFold Architecture and Docking Modalities

AlphaFold 2 employs an attention-based neural network that integrates multiple sequence alignments (MSAs) and pairwise residue features to produce accurate protein backbone and side-chain coordinates [3]. The model's predicted local distance difference test (pLDDT) score provides per-residue confidence, which is critical for downstream docking applications [4, 5]. AlphaFold 3 uses a diffusion-based architecture that generates joint structures of biomolecular complexes, including small-molecule ligands, without requiring separate docking steps [3, 6]. This advance allows co-folding, where the protein and ligand are jointly sampled, potentially capturing induced-fit effects that traditional rigid-receptor docking cannot [3, 7].

Despite these advances, direct application of AlphaFold models for docking presents challenges. Local conformational errors in predicted structures can reduce docking success rates, particularly in flexible loop regions and multidomain proteins [5]. The models may also struggle with alternative conformational states; for example, AlphaFold 2 and AlphaFold 3 show a bias toward specific conformations of transport proteins such as the ADP/ATP carrier [8]. Such biases necessitate careful evaluation of model suitability for each target system.

Methodological Framework for Protein-Ligand Docking with AlphaFold Models

The general workflow for AlphaFold-based docking involves: (1) generating a predicted protein structure using AlphaFold or related tools, (2) identifying potential binding sites via computational mapping or sequence-based methods, (3) performing molecular docking using classical or deep learning-based docking algorithms, and (4) scoring and ranking poses. This pipeline has been extensively evaluated using Glide, AutoDock Vina, and other docking engines [1, 9, 10, 11]. A systematic comparison showed that fragment docking to AlphaFold models outperforms docking to unbound (apo) crystal structures and performs comparably to docking to ligand-bound (holo) structures when binding sites are identified in an unbiased manner [1, 2]. For larger ligands, docking to ensembles of AlphaFold models improves performance compared to using a single model [1].

Binding hot spot mapping using fragment probes (e.g., FTMap) provides a reliable method for identifying binding sites on AlphaFold-predicted structures, often with success rates only 5–10% lower than mapping on X-ray structures [5]. For multidomain proteins, generating models for individual ligand-binding domains rather than full-length constructs substantially improves mapping and docking accuracy [5]. The trimming of poorly predicted flexible termini or loops from AlphaFold structures can also enhance docking performance by reducing false positive poses and computational demands [9].

Deep learning-based docking methods such as FlowDock, Interformer, and FeatureDock have emerged as alternatives to classical sampling-based approaches [12, 13, 14]. FlowDock uses conditional flow matching to map unbound (apo) structures to their bound (holo) counterparts, achieving a 51% blind docking success rate on the PoseBusters benchmark using unbound AlphaFold input structures [12]. Interformer captures non-covalent interactions through an interaction-aware mixture density network, advancing state-of-the-art performance in both docking and affinity prediction [14]. FeatureDock leverages transformer-based learning of local physicochemical features for pose prediction and virtual screening [13].

Benchmarking and Performance Assessment

Multiple large-scale benchmarks have evaluated AlphaFold-based docking. The PoseBench benchmark systematically compared deep learning co-folding methods (including AlphaFold 3) with classical docking tools, finding that co-folding generally outperforms conventional and deep learning docking baselines, yet AlphaFold 3 itself remains challenged by targets with novel binding poses [15]. The 16th Critical Assessment of Structure Prediction (CASP16) included protein-ligand categories; template-guided ensemble docking strategies combining AlphaFold models with alignment-based docking (e.g., LSalign) and knowledge-based scoring (ITScore) achieved high accuracy, ranking fourth among 38 participating teams [16]. AlphaFold 3 also demonstrated strong performance in CASP16 baseline tests, outperforming many participants and dedicated docking tools for pose prediction, though ligand affinity prediction remains unreliable [7].

The VirtualBindPredict framework provides a sequence-based alternative that bypasses explicit structure prediction, using deep learning to predict viral protein-ligand binding sites directly from sequence embeddings (ESM2, ProtTrans) combined with ligand descriptors [17]. This approach is particularly valuable for targets where AlphaFold models may be inaccurate due to high flexibility or lack of homologous templates.

Benchmarking on microbial proteomes, such as the essential proteome of Escherichia coli, revealed that combining AlphaFold 2 with molecular docking for antibacterial compounds yielded weak average performance (auROC 0.48), though rescoring with machine learning improved it to 0.63 [10]. This highlights the need for advanced scoring functions, such as those integrated in CarsiDock, which uses large-scale pre-training on millions of protein-ligand complexes to achieve improved docking accuracy and virtual screening enrichment [18].

Structural Flexibility and Conformational Sampling

Proteins are inherently dynamic, and ligand binding often involves conformational changes that are not captured by single AlphaFold predictions. Ensemble docking, where multiple conformations are generated and docked independently, addresses this limitation. AlphaFold 2 subsampling (generating multiple models by varying the random seed or MSA depth) produces conformational ensembles that can be used for ensemble docking [1, 19]. For mutated proteins, subsampling combined with Gaussian fitting to select the most likely states improved prediction of relative binding affinity changes induced by mutations in kinases [19].

Molecular dynamics (MD) simulations further refine AlphaFold models by sampling alternative conformations. For the mitochondrial ADP/ATP carrier, AlphaFold models combined with MD simulations provided insights into substrate binding and the effects of pathogenic mutations on conformational dynamics [8]. Similarly, hybrid approaches that integrate physics-based sampling (e.g., ClusPro FFT docking) with AlphaFold-based refinement have produced high-accuracy complex models for protein-protein and protein-ligand interactions [20].

Deep learning models that implicitly incorporate flexibility, such as those predicting intermolecular distance matrices (EDMs) for flexible docking, also benefit from AlphaFold input structures [21].

Model Selection and Refinement Strategies

Given multiple AlphaFold-generated models of the same protein, selecting the most suitable structure for docking is a non-trivial task. The RevBind method leverages information from multiple known ligands: by comparing predicted ligand poses across models, it identifies the model that best reproduces consistent binding interactions [22]. This approach outperforms traditional metrics such as pLDDT or clash scores for selecting docking-ready conformations.

Refinement of AlphaFold models using induced-fit docking (IFD-MD) with a known ligand as a template can significantly enhance virtual screening performance, raising early enrichment factors from an average of 13.0 (native AF2) to 18.9 [11]. The trimming of poorly predicted surface loops, as described earlier, further improves docking outcomes [9].

For environmental contaminants such as per- and polyfluoroalkyl substances (PFAS), a hybrid approach combining AlphaFold 3 with AutoDock Vina, especially when considering multiple top-ranked poses, improved prediction accuracy compared to using AF3 alone [23]. This demonstrates the value of integrating classical docking with deep learning predictions.

Applications in Veterinary Drug Discovery and Viral Target Identification

AlphaFold-based docking has direct applications in veterinary medicine, particularly for identifying drug targets in animal pathogens. The computational pipeline "reAlldock" performs high-throughput docking across the entire AlphaFold 2-predicted structural proteome of organisms such as mouse or target animal species [24, 4]. Applied to the nephrotoxin puberulic acid, this pipeline identified sodium/myo-inositol cotransporter 2 as a high-affinity target in both human and mouse, suggesting a mechanism of renal osmoregulation disruption [4]. Such approaches can be extended to veterinary toxicology and drug safety assessment.

For viral pathogens, the integration of AlphaFold with docking enables rapid screening of antiviral compounds against predicted structures of viral proteins. The ViralBindPredict benchmark provides the first large-scale, leakage-controlled benchmark for viral protein-ligand interactions, covering over 10,000 viral chains and 13,000 interactions [17]. This resource supports sequence-based prediction of binding residues even when high-quality structural models are unavailable.

The structural prediction of viral envelope glycoproteins using AlphaFold 2 has implications for host receptor binding and vaccine design, as described in related articles on this portal (e.g., Structural Prediction of Viral Envelope Glycoproteins Using AlphaFold2 and AlphaFold 3 in Molecular Biology). Docking of small-molecule ligands to these predicted glycoprotein structures can identify potential entry inhibitors. Similarly, computational analysis of viral protease inhibitors and drug resistance (see Computational Analysis of Viral Protease Inhibitors and Drug Resistance) can benefit from accurate AlphaFold models of mutant variants.

The performance of AlphaFold for GPCR-ligand docking has been assessed in the 4th GPCR Dock competition, where AI-powered modeling achieved accuracy comparable to or exceeding low-resolution experimental structures for peptide ligands [25]. This has direct relevance for veterinary neuropharmacology and endocrinology.

Computational Workflow Diagram

The following Mermaid diagram illustrates a typical computational workflow for AlphaFold-based protein-ligand docking, incorporating both classical and deep learning steps.

flowchart TD
    A[Target protein sequence], > B[AlphaFold2/3 structure prediction]
    B, > C{pLDDT confidence filter}
    C, >|Low confidence regions| D[Trimming of flexible loops/termini]
    C, >|High confidence| E[Binding site identification]
    D, > E
    E, > F[FTMap hot spot mapping or sequence-based prediction]
    F, > G[Ligand library preparation]
    G, > H[Ensemble docking with classical engine (e.g., Glide/Vina)]
    G, > I[Deep learning co-folding (e.g., AlphaFold3, FlowDock)]
    H, > J[Pose scoring and ranking]
    I, > J
    J, > K[Rescoring with machine learning (e.g., ITScore, Interformer)]
    K, > L[Top poses for MD refinement or experimental validation]

Figure 1. Representative computational pipeline for protein-ligand docking using AlphaFold models.

Comparative Table of Docking Approaches

Table 1. Comparison of major approaches for protein-ligand docking using AlphaFold-derived structures.

Future Directions and Challenges

Despite the remarkable progress, several challenges remain. AlphaFold models often fail to capture alternative protein conformations, particularly for membrane transporters and GPCRs [8, 25]. Disordered regions and cryptic binding sites are poorly modeled, limiting applications for intrinsically disordered proteins [6, 7]. Ligand binding affinity prediction from AlphaFold structures remains unreliable, as demonstrated in CASP16 assessments [7]. The Folding-Docking-Affinity (FDA) framework attempts to bridge this gap by integrating binding structure prediction with affinity prediction, but performance still lags behind docking-free methods [26].

Integration with experimental data, such as cryo-electron microscopy maps (see Cryo-EM Density Map Interpretation and Computational Structure Fitting) and crosslinking mass spectrometry, may improve model accuracy for challenging targets. Continued development of deep learning methods that can predict both pose and affinity with high confidence will be essential for translating AlphaFold-based docking into routine preclinical drug discovery pipelines, including those for veterinary applications.

References

[1] Maidanik H, Lazou M, Bajaj R, et al. Assessment of Alphafold Protein Models for Small-Molecule Ligand Docking versus Co-Folding. Journal of Chemical Information and Modeling. 2026. https://www.semanticscholar.org/paper/9d207c5c1d52ce43e48c60fddfd3baee2379dd30

[2] Maidanik H, Lazou M, Bajaj R, et al. ASSESSMENT OF ALPHAFOLD PROTEIN MODELS FOR SMALL-MOLECULE LIGAND DOCKING. bioRxiv. 2026. https://www.semanticscholar.org/paper/0de5b57916340d24033b17fb9f222f09113ab280

[3] Abramson J, Adler J, Dunger J, et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature. 2024. https://www.semanticscholar.org/paper/7572ba7f604ef95d7acdd657ebac458106bd35df

[4] Hayama T, Sugawara R, Kamata R, et al. Comprehensive molecular docking on the AlphaFold-predicted protein structure proteome: identifying target protein candidates for puberulic acid. Journal of Toxicological Sciences. 2025. https://www.semanticscholar.org/paper/93c518943a31332a8ca0ed30814970738ab426f6

[5] Bekar-Cesaretli AA, Khan O, Nguyen T, et al. Conservation of Hot Spots and Ligand Binding Sites in Protein Models by AlphaFold2. Journal of Chemical Information and Modeling. 2024. https://www.semanticscholar.org/paper/bae934c634e509191807012f1d4eb2153d99e307

[6] Krokidis MG, Koumadorakis DE, Lazaros K, et al. AlphaFold3: An Overview of Applications and Performance Insights. International Journal of Molecular Sciences. 2025. https://www.semanticscholar.org/paper/efac4a5106c365608b0b98ac87081a29f6c2d2b2

[7] Abriata L, Dal Peraro M. Practical Outcomes From CASP16 for Users in Need of Biomolecular Structure Prediction. Proteins: Structure, Function, and Bioinformatics. 2025. https://www.semanticscholar.org/paper/0c27f169866dde48e54bfa29dda5bb2ac79fd0a7

[8] Quadrotta V, Polticelli F. Modeling the different conformations of the human mitochondrial ADP/ATP carrier using AlphaFold and molecular dynamics simulations of the protein-ligand complexes. Computational and Structural Biotechnology Journal. 2025. https://www.semanticscholar.org/paper/38a5e792606922d15932fafd5cc6c6f69fa281ff

[9] Klein-Seetharaman R, Jennewein T, Harms C, et al. Trimming of AlphaFold Predicted Protein Structures for Functional Characterization. ICCBB. 2024. https://www.semanticscholar.org/paper/e6e4fd620b789b5ad5cdb0746fdb87e60e663b10

[10] Wong F, Krishnan A, Zheng EJ, et al. Benchmarking AlphaFold‐enabled molecular docking predictions for antibiotic discovery. Molecular Systems Biology. 2022. https://www.semanticscholar.org/paper/df31d66aaabe5171b045274685321178b85e9af3

[11] Zhang Y, Vass M, Shi D, et al. Benchmarking Refined and Unrefined AlphaFold2 Structures for Hit Discovery. Journal of Chemical Information and Modeling. 2023. https://www.semanticscholar.org/paper/3085768d63e0fe3b6044b378abdf08aa39db0564

[12] Morehead A, Cheng J. FlowDock: Geometric flow matching for generative protein–ligand docking and affinity prediction. Bioinformatics. 2025. https://www.semanticscholar.org/paper/d16229b64ec6a433aab8e9994ac62f7e8f2331e3

[13] Xue M, Liu B, Cao S, et al. FeatureDock for protein-ligand docking guided by physicochemical feature-based local environment learning using transformer. npj Drug Discovery. 2025. https://www.semanticscholar.org/paper/69c748ee87a302b0b8451cc1648e53287f995069

[14] Lai H, Wang L, Qian R, et al. Interformer: an interaction-aware model for protein-ligand docking and affinity prediction. Nature Communications. 2024. https://www.semanticscholar.org/paper/26f6c2514318d55851d6985b72955143c043ebeb

[15] Morehead A, Giri N, Liu J, et al. Assessing the potential of deep learning for protein–ligand docking. Nature Machine Intelligence. 2025. https://www.semanticscholar.org/paper/dea5916fbe42e66218ecf0065cb7a5a0e5afc598

[16] Zhang K, Wu Q, Huang S. Protein–Ligand Structure Prediction by Template‐Guided Ensemble Docking Strategy. Proteins: Structure, Function, and Bioinformatics. 2025. https://www.semanticscholar.org/paper/73abacecef9832c9e8c810529d57932d47007df6

[17] Amorim AM, Marques-Pereira C, Almeida T, et al. ViralBindPredict: empowering viral protein–ligand binding sites through deep learning and protein sequence-derived insights. GigaScience. 2026. https://www.semanticscholar.org/paper/99b416238f1b3d0e4524d5161e2a4463e598b0ac

[18] Cai H, Shen C, Jian T, et al. CarsiDock: a deep learning paradigm for accurate protein–ligand docking and screening based on large-scale pre-training. Chemical Science. 2023. https://www.semanticscholar.org/paper/12f90a54c1f94981ba4f129be8b220b4b8282b6a *** Disclaimer: This article is for educational and informational purposes only. It is not intended to substitute for professional veterinary advice, diagnosis, treatment, or regulatory guidance. Always consult a licensed veterinarian or qualified specialist regarding animal health, disease diagnosis, and therapeutic decisions.

[19] Xie L, Lu X, Zhang D, et al. Predicting Mutation-Induced Relative Protein-Ligand Binding Affinity Changes via Conformational Sampling and Diversity Integration with Subsampled Alphafold2 in Few-Shot Learning. bioRxiv. 2025. https://www.semanticscholar.org/paper/20fa0e4196191dc3d44b5512736fc7bcf952f52d

[20] Ashizawa R, Kotelnikov S, Khan O, et al. Modeling Protein–Protein and Protein–Ligand Interactions by the ClusPro Team in CASP16. Proteins: Structure, Function, and Bioinformatics. 2025. https://www.semanticscholar.org/paper/fef29a0f4b22320849d4ff51e0c209dcbcff2b22

[21] Masters M, Mahmoud AH, Wei Y, et al. Deep Learning Model for Efficient Protein-Ligand Docking with Implicit Side-Chain Flexibility. Journal of Chemical Information and Modeling. 2023. https://www.semanticscholar.org/paper/b29d66e1c466bd248232eee0d987118b258fb18e

[22] Karelina M, Dror RO. Protein structural model selection informed by comparison of predicted ligand binding poses. Journal of Chemical Information and Modeling. 2025. https://www.semanticscholar.org/paper/449938ff093aa3bb054f653297d688cb11eb79fd

[23] Gong X, Zhou H, Huang Q. Assessing AlphaFold 3 for Per- and Polyfluoroalkyl Substances Docking in Protein Structures. Environmental Science and Technology. 2025. https://www.semanticscholar.org/paper/92934e2d751976d631573f2010ed73b5edea27a2

[24] Hayama T, Sugawara R, Kamata R, et al. Comprehensive Molecular Docking on the AlphaFold-Predicted Protein Structure Proteome: Identifying Target Protein Candidates for Puberulic Acid, a Suspected Lethal Nephrotoxin. bioRxiv. 2025. https://www.semanticscholar.org/paper/8e9d220b60c280ec6fbfe284969d3725cc151563

[25] Chitsazi R, Wu Y, Stevens RC, et al. The 4th GPCR Dock: assessment of blind predictions for GPCR-ligand complexes in the era of AlphaFold. bioRxiv. 2025. https://www.semanticscholar.org/paper/9993e125d585b9540edd4dc0e56f27b69802b7bc

[26] Wu M-H, Xie Z, Zhi D. A Folding-Docking-Affinity framework for protein-ligand binding affinity prediction. bioRxiv. 2025. https://www.semanticscholar.org/paper/6ab670d6873d77847b98da921d646d92e8c28547

[27] Mamchur A, Ivanov M, Matkava L, et al. Tackling APOE's structural challenges via in silico modeling in the era of neural networks: can AlphaFold II help circumvent the problem of lacking full-length protein structure? Archives of Biochemistry and Biophysics. 2024. https://www.semanticscholar.org/paper/89d8d9a7654ddb6b99aa6e1bc13f76a4304e2bbe

[28] Tejera-Nevado P, Junod N, Kwon EH, et al. Benchmarking Docking Tools on Experimental and Artificial Intelligence-Predicted Protein Structures. bioRxiv. 2025. https://www.semanticscholar.org/paper/045415272b2d26747568e2df61e71fb38afdfec1

[29] Ciancetta A, Malfacini D, Gozzi M, et al. A Multi-Angle Approach to Predict Peptide-GPCR Complexes: The N/OFQ-NOP System as a Successful AlphaFold Application Case Study. Journal of Chemical Information and Modeling. 2024. https://www.semanticscholar.org/paper/1bf27a3c1e688e1df01d0c6fef1ab77da5f4f6ae

[30] Le Menestrel T, Rivas MA. Smiles2Dock: an open large-scale multi-task dataset for ML-based molecular docking. arXiv.org. 2024. https://www.semanticscholar.org/paper/a257fb071d9345238f63d8b644d560b2ede671d4

[31] Performance and structural coverage of the latest, in-development AlphaFold model. Journal. https://www.semanticscholar.org/paper/6506d9992e9657aacc4bebe9ceba89b1e416f39f

[32] Verdonk M, Cole J, Hartshorn M, et al. Improved protein–ligand docking using GOLD. Proteins: Structure, Function, and Bioinformatics. 2003. https://www.semanticscholar.org/paper/b6a3ef458d91e1ceb2b4967f879f81d265c918a8

[33] Zayed A. Optimizing protein-ligand docking through machine learning: algorithm selection with AutoDock Vina. Discover Chemistry. 2025. https://www.semanticscholar.org/paper/7bfc48ea1734aa8fc0a0ee660bf493e4a1ebadf9

[34] Forli S, Huey R, Pique M, et al. Computational protein-ligand docking and virtual drug screening with the AutoDock suite. Nature Protocols. 2016. https://www.semanticscholar.org/paper/e46b21ae431955917538f3f9e27c34e6a4d443d6

[35] Baroroh U, Muscifa ZS, Destiarani W, et al. Molecular interaction analysis and visualization of protein-ligand docking using Biovia Discovery Studio Visualizer. Indonesian Journal of Computational Biology (IJCB). 2023. https://www.semanticscholar.org/paper/181268942c6539bd9dba12f20a4b21e2bb170b5d